Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Adalimumab Effective in Patients With Total Spinal Ankylosis
Link ID 9315
Title Adalimumab Effective in Patients With Total Spinal Ankylosis
Url http://www.medscape.com/viewarticle/581394?src=rss
Description Treatment with the TNF-blocker adalimumab leads to rapid and clinically significant improvement in the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis, according to results of a controlled trial reported in the September issue of Annals of the Rheumatic Diseases. Reuters Health Information
Category Articles > Rheumatology
Keywords
Date Oct 3, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Diagnosis, Management and Prevention of Scleroderma Renal Disease
  Renal complications are important in scleroderma (systemic sclerosis) and include scleroderma renal crisis. Key aspects of management and outcome are reviewed.
Current Opinion in Rheumatology
Category:   Articles > Rheumatology


2. Methotrexate Spares Steroid Use in Moderately Active SLE
  Patients with moderately active systemic lupus erythematosus (SLE) can significantly benefit from methotrexate with folic acid, according to researchers with the Canadian Network for Improved Outcomes in SLE. Reuters Health Information
Category:   Articles > Rheumatology


3. Vitamin D in Systemic Lupus Erythematosus
  Prospective studies of vitamin D in systemic lupus erythematosus are limited, but most cross-sectional studies show an inverse relationship between levels of vitamin D and disease activity.
Current Opinion in Rheumatology
Category:   Articles > Rheumatology


4. Vitamin D and Bone Health in Adults With Cystic Fibrosis
  Cystic fibrosis patients have chronic pancreatic insufficiency leading to malabsorption of fat-soluble vitamins, including vitamin D which can contribute to poor skeletal health and respiratory function.
Clinical Endocrinology
Category:   Articles > Rheumatology


5. FDA Panel Says No to Canakinumab for Gout AttacksFDA Panel Says No to Canakinumab for Gout Attacks
  For the FDA Arthritis Advisory Committee, the injectable biologic canakinumab may be promising for a niche group of patients, but fears about long-term safety kept them from voting for its approval. br / iMedscape Medical News/i
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS